As for high-grade (G3–G4) tumors, positive immunolabelling for STING (H-score > 5) was noticed in 21 of the 56 G3 neoplasms (37%) and 22 of the 34 G4 ones (65%). The gene discussed is STING1; the disease is neoplasm.